Status:
UNKNOWN
Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury
Lead Sponsor:
Hamamatsu University
Conditions:
Kidney Failure
Eligibility:
All Genders
Brief Summary
We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the chang...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hospitalized patients have neck cancer
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00310739
Last Update
November 7 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamamatsu University School of Medicine
Hamamatsu, Shizuoka, Japan, 431-3192